Cozen O'Connor snaps up Kilpatrick Townsend duo
28-10-2020
Fed Circuit refuses Amgen unit appeal in win for Sanofi
15-10-2020
Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms
06-10-2020
Grand Warszawski / Shutterstock.com
Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Kilpatrick Townsend & Stockton, DLA Piper, life sciences, patent litigation, Hatch-Waxman, innovation, biotech
